- Home
- ADXN vs DSS Comparison
ADXN vs DSS Comparison
Compare ADXN & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- DSS
- Stock Information
- Founded
- ADXN 2002
- DSS 1984
- Country
- ADXN Switzerland
- DSS United States
- Employees
- ADXN N/A
- DSS N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- DSS Containers/Packaging
- Sector
- ADXN Health Care
- DSS Consumer Discretionary
- Exchange
- ADXN Nasdaq
- DSS Nasdaq
- Market Cap
- ADXN 8.1M
- DSS 8.0M
- IPO Year
- ADXN N/A
- DSS N/A
- Fundamental
- Price
- ADXN $7.90
- DSS $0.88
- Analyst Decision
- ADXN Strong Buy
- DSS
- Analyst Count
- ADXN 1
- DSS 0
- Target Price
- ADXN $30.00
- DSS N/A
- AVG Volume (30 Days)
- ADXN 4.6K
- DSS 12.0K
- Earning Date
- ADXN 06-05-2025
- DSS 05-20-2025
- Dividend Yield
- ADXN N/A
- DSS N/A
- EPS Growth
- ADXN N/A
- DSS N/A
- EPS
- ADXN 0.06
- DSS N/A
- Revenue
- ADXN $701,260.00
- DSS $19,097,000.00
- Revenue This Year
- ADXN N/A
- DSS N/A
- Revenue Next Year
- ADXN N/A
- DSS N/A
- P/E Ratio
- ADXN $1.05
- DSS N/A
- Revenue Growth
- ADXN N/A
- DSS N/A
- 52 Week Low
- ADXN $6.51
- DSS $0.72
- 52 Week High
- ADXN $13.27
- DSS $1.94
- Technical
- Relative Strength Index (RSI)
- ADXN 51.90
- DSS 41.65
- Support Level
- ADXN $7.72
- DSS $0.72
- Resistance Level
- ADXN $8.07
- DSS $0.98
- Average True Range (ATR)
- ADXN 0.30
- DSS 0.07
- MACD
- ADXN 0.04
- DSS -0.01
- Stochastic Oscillator
- ADXN 62.50
- DSS 53.57
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.